Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LEMAITRE VASCULAR INC Director's Dealing 2017

Dec 27, 2017

31708_dirs_2017-12-27_4629394d-3ec1-40f4-8453-0a8dac61cba0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2017-12-22

Reporting Person: Thomas Michael H (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-12-22 Stock Option (Right to Buy) $31.30 A 7500 Acquired 2022-12-22 Common Stock (7500) Direct

Footnotes

F1: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years.